Descrição
Initial findings from a randomized controlled trial examining magnesium and vitamin B6 supplementation in patients with restless legs syndrome (RLS/Willis-Ekbom Disease). The data present baseline characteristics or early efficacy measures for the intervention groups.
Figure 1
ChartSource Paper
Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial.Cite This Figure
![Figure 1: Initial findings from a randomized controlled trial examining magnesium and vitamin B6 supplementation in patients with restless legs syndrome (RLS/Willis-Ekbom Disease). The data present baseline characteristics or early efficacy measures for the intervention groups.]() > Source: Ali Jadidi et al. "Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of r." *BMC complementary medicine and therapies*, 2022. PMID: [36587225](https://pubmed.ncbi.nlm.nih.gov/36587225/)
<figure> <img src="" alt="Initial findings from a randomized controlled trial examining magnesium and vitamin B6 supplementation in patients with restless legs syndrome (RLS/Willis-Ekbom Disease). The data present baseline characteristics or early efficacy measures for the intervention groups." /> <figcaption>Figure 1. Initial findings from a randomized controlled trial examining magnesium and vitamin B6 supplementation in patients with restless legs syndrome (RLS/Willis-Ekbom Disease). The data present baseline characteristics or early efficacy measures for the intervention groups.<br> Source: Ali Jadidi et al. "Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of r." <em>BMC complementary medicine and therapies</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36587225/">36587225</a></figcaption> </figure>